Lithuania vs Mauritius: The number of people with susceptibility test result for rifampicin
Lithuania
100
in 2021
Mauritius
100
in 2021
Lithuania rank
2nd
Mauritius rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Lithuania
- Mauritius
How they compare
Lithuania currently reports 100 against 100 in Mauritius, a difference of 0.
Across all 5 years both countries report, Mauritius has been ahead every year.
Lithuania ranks 2nd and Mauritius ranks 2nd of 146 countries.
Head to head by decade
| Decade | Lithuania | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 100 | 0 | — |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lithuania or Mauritius?
- Lithuania, at 100 against 100 in Mauritius as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lithuania and Mauritius?
- 0, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Mauritius?
- 5 years are reported by both, from 2017 to 2021.
- How do Lithuania and Mauritius rank globally for the number of people with susceptibility test result for rifampicin?
- Lithuania ranks 2nd and Mauritius ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.